They will use a smaller needle to give subcutaneous injections to ensure the medication enters the fatty tissue and not the muscle. Unlike muscle tissue, subcutaneous tissue has few blood vessels, ...

While administering monoclonal antibodies via intravenous infusion is standard practice to prevent severe hospitalization and death in outpatients with COVID-19, new research from UPMC shows giving ...

Receiving monoclonal antibodies to treat COVID-19 used to be a time-consuming process at the UPMC Hamot Infusion Center. The intravenous treatment took about 30 minutes, which came after a nearly hour ...

Three years after its initial FDA approval, Roche has made up for an early disadvantage with its blood cancer drug Lunsumio ...

If you have certain types of arthritis or if you’re having a certain transplant, your doctor might suggest Orencia (abatacept) as a treatment option for you. Orencia is a prescription medication ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New research suggests that the casirivimab-imdevimab monoclonal antibody treatment for COVID-19 ...

Kesimpta is a medicine used to treat relapsing forms of multiple sclerosis (MS). Relapsing forms of MS include clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS ...